Just a moment...
www.fiercebiotech.com
Non catégorisé
Chutes & Ladders—Former Roche oncology head turns to Tubulis
Non catégorisé
Baby KJ scientist launches personalized CRISPR therapy startup
Non catégorisé
AirNexis takes flight with $200M, links up with China pharma for COPD asset in $955M biobucks deal
Non catégorisé
Orca rides $250M funding wave toward cancer cell therapy launch
Non catégorisé
3 new venture funds collect nearly $1B for biotech in US, EU
Non catégorisé
Roche returns to MediLink with promise of $570M near-term payments for another ADC
Non catégorisé
Immuneering touts 64% 1-year survival, keeping wheels turning in race with Revolution
Non catégorisé
Innovation isn't enough: Biopharma needs urgent reinvention, PwC says
Non catégorisé
Diagonal moves forward with $125M series B round, plots first-in-human study this year
Non catégorisé
FDA cites severe liver injury risk, unclear benefit behind Sanofi's MS drug rejection
Non catégorisé
UK biotech eyes $1B deal to enable eye gene therapy to be delivered in doctors' offices
Non catégorisé
Gilead garners lipid package for cancer asset in $300M research pact
Non catégorisé
Pfizer charts course to tumor-selective antigens in $865M Cartography collab
Non catégorisé
Instil's stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco
Non catégorisé
BrainSpace garners FDA clearance for brain fluid management system
Non catégorisé
Cash-strapped TME Pharma loses partner, prompting eye drug strategy rethink
Non catégorisé
Sanofi's latest autoimmune bispecific pact with AI biotech could reach $2.5B
Non catégorisé